These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6968847)

  • 1. Inhibition of B-lymphocyte clonal proliferation by spleen cells from plasmacytoma-bearing mice.
    Hamburger AW
    J Natl Cancer Inst; 1980 Dec; 65(6):1337-43. PubMed ID: 6968847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of plasmacytomas on serum immunoglobulin levels of BALB/c mice.
    Fenton MR; Havas HF
    J Immunol; 1975 Feb; 114(2 pt 2):793-801. PubMed ID: 1089719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclophosphamide-induced appearance of immunopotentiating T-cells in the spleens of mice bearing a large MOPC-315 tumor.
    Ye QW; Mokyr MB
    Cancer Res; 1984 Sep; 44(9):3873-9. PubMed ID: 6611201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of the humoral immune response by plasmacytomas: mediation by adherent mononuclear cells.
    Kolb JP; Arrian S; Zolla-Pazner S
    J Immunol; 1977 Feb; 118(2):702-9. PubMed ID: 138708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
    Flood PM; Philipps C; Taupier MA; Schreiber H
    J Immunol; 1980 Jan; 124(1):424-30. PubMed ID: 6965296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocompetence status as related to growth progression of mouse MOPC-315 plasmacytoma.
    Rashid G; Ophir R; Pecht M; Ben-Efraim S
    In Vivo; 1989; 3(4):279-84. PubMed ID: 2535271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matching of chemotherapy to mouse strain and lymphoid tumor type to prevent tumor-induced suppression of specific T- and B-cell functions.
    Faanes RB; Merluzzi VJ; Williams N; Tarnowski GS; Ralph P
    Cancer Res; 1979 Nov; 39(11):4564-74. PubMed ID: 315269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of B cell proliferation: arrest of B cells in late G1 underlies immunosuppression induced by plasma cell tumors.
    Berman JE; Zolla-Pazner S
    J Immunol; 1987 May; 138(9):2805-12. PubMed ID: 3494771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloma-induced immunosuppression: a multistep mechanism.
    Katzmann JA
    J Immunol; 1978 Oct; 121(4):1405-9. PubMed ID: 701801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of T, B and adherent cells in the in vitro immune response of TEPC-183-bearing mice.
    Patel M; Havas HF
    Immunology; 1982 May; 46(1):97-105. PubMed ID: 6978846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of the cells generating B-lymphocyte colonies in vitro.
    Metcalf D; Wilson JW; Shortman K; Miller JF; Stocker J
    J Cell Physiol; 1976 May; 88(1):107-16. PubMed ID: 1083394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Neoplastic-lymphocytic hybrid cell lines].
    Izdebska-Szymona K
    Postepy Hig Med Dosw; 1979; 33(5):465-77. PubMed ID: 398040
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B lymphocyte lineage cells in newborn and very young NZB mice: evidence for regulatory disorders affecting B cell formation.
    Jyonouchi H; Kincade PW; Good RA; Gershwin ME
    J Immunol; 1983 Nov; 131(5):2219-25. PubMed ID: 6605377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in B lineage cell population in liver and spleen of normal neonatal mice.
    Jyonouchi H; Kincade PW
    J Immunol; 1983 Apr; 130(4):1616-21. PubMed ID: 6601130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a bioassay for human myeloma colony-forming cells.
    Hamburger AW; Salmon SE
    Prog Clin Biol Res; 1980; 48():23-41. PubMed ID: 7208518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppression in BALB/c mice bearing the plasmacytoma TEPC-183: massive increase in red pulp macrophages induced by the tumour.
    Joshua DE; Humphrey JH; Grennan D; Brown G
    Immunology; 1980 Jun; 40(2):223-8. PubMed ID: 7409859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of splenectomy on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).
    Havas HF; Berney S; Goodis A; Schiffman G
    Cancer Res; 1979 Sep; 39(9):3783-7. PubMed ID: 476702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular changes and antitumor responses in the plasmacytoma-bearing mouse following cyclophosphamide treatment.
    Shanahan TC; Ceglowski WS; Havas HF
    Cancer Res; 1985 Dec; 45(12 Pt 1):6463-70. PubMed ID: 2866030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.